Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Common Equity (2022 - 2025)

Vsee Health filings provide 4 years of Common Equity readings, the most recent being $5.5 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 29591.39% to $5.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.5 million, a 29591.39% increase, with the full-year FY2025 number at $5.5 million, up 29591.39% from a year prior.
  • Common Equity hit $5.5 million in Q4 2025 for Vsee Health, up from -$5.6 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $5.5 million in Q4 2025 to a low of -$5.7 million in Q2 2025.
  • Median Common Equity over the past 4 years was -$1.4 million (2023), compared with a mean of -$1.8 million.
  • The widest YoY moves for Common Equity: up 29591.39% in 2025, down 697.51% in 2025.
  • Vsee Health's Common Equity stood at -$574066.0 in 2022, then plummeted by 648.96% to -$4.3 million in 2023, then skyrocketed by 99.57% to -$18488.0 in 2024, then soared by 29591.39% to $5.5 million in 2025.
  • The last three reported values for Common Equity were $5.5 million (Q4 2025), -$5.6 million (Q3 2025), and -$5.7 million (Q2 2025) per Business Quant data.